Pharma Market Forecast: Antipsychotics to 2011

Published by: Datamonitor

Published: Oct. 31, 2003

Table of Contents

Please Note: Due to the brevity and/or nature of the content posted, there is no table of contents available for this report.

Abstract

Pharma Market Forecast: Antipsychotics to 2011 is a user-friendly Excel-based interactive market model, which provides comprehensive and transparent global sales forecasts of both inline and pipeline products to 2011. This interactive model complements the analysis and forecasts in Datamonitor's in-depth analysis "Pipeline Insight: Antipsychotics".

• Provides sales forecasts for Lundbeck's Serdolect, Lundbeck/Solvay's Bifeprunox, Dainippon's Lonasen, Organo/Pfizer's Asenapine to 2011
• Models the predicted negative impacts of Risperdal and Geodon patent expiries in 2007 and resultant genericization
• Projects the sales growth of BMS's Abilify; the greatest positive impact on the antipsychotic market over the forecast period

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 160,000 market research reports, company profiles and country profiles from over 600 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.